However, CK1α is not the only protein with this characteristic, and therefore dual degraders have been developed which target CK1α and Helios (IKZF2), which have demonstrated efficacy in cell lines representing ovarian cancer and diffuse large B cell lymphoma [109,110]. The gene discussed is CSNK1A1; the disease is diffuse large B-cell lymphoma.